The topoisomerase I inhibitor topotecan increases the sensitivity of prostate tumor cells to TRAIL/Apo-2L-induced apoptosis Thomas S. GriffithTroy J. Kemp Original Article 14 June 2003 Pages: 175 - 184
Role of mismatch repair in the induction of chromosomal aberrations and sister chromatid exchanges in cells treated with different chemotherapeutic agents Patrizia VernoleRita PepponiStefania D'Atri Original Article 19 June 2003 Pages: 185 - 192
Pharmacokinetics of capecitabine (Xeloda) in Japanese and Caucasian patients with breast cancer Bruno ReignerToru WatanabeSusan Grange Original Article 29 May 2003 Pages: 193 - 201
Peptides designed from molecular modeling studies of the ras-p21 protein induce phenotypic reversion of a pancreatic carcinoma cell line but have no effect on normal pancreatic acinar cell growth Mecheal KanovskyJosef MichlMatthew R. Pincus Original Article 29 May 2003 Pages: 202 - 208
Population pharmacokinetics of oral busulfan in children Brunhild SchiltmeyerThomas KlingebielGeorg Hempel Original Article 17 June 2003 Pages: 209 - 216
Phase I combination trial of gemcitabine, paclitaxel, and carboplatin in patients with advanced malignancy Keith T. FlahertyJames P. StevensonPeter J. O'Dwyer Original Article 17 June 2003 Pages: 217 - 222
Amifostine does not reduce the toxicity of the fludarabine and cyclophosphamide regimen in patients with chronic lymphocytic leukemia Francis J. GilesGary Guangping ShiSusan M. O'Brien Original Article 03 June 2003 Pages: 223 - 228
Anagrelide and imatinib mesylate combination therapy in patients with chronic myeloproliferative disorders Apostolia M. TsimberidouDawn E. ColburnFrancis J. Giles Original Article 29 May 2003 Pages: 229 - 234
Sensitization of human breast cancer cells to gemcitabine by the protein kinase C modulator bryostatin 1 Shadan AliOlivia AranhaPhilip Agop Philip Original Article 14 June 2003 Pages: 235 - 246
Combination of low-dose cisplatin and gemcitabine for treatment of elderly patients with advanced non-small-cell lung cancer J. FeliuG. MartínM. González-Barón Original Article 29 May 2003 Pages: 247 - 252
The activity of camptothecin analogues is enhanced in histocultures of human tumors and human tumor xenografts by modulation of extracellular pH James L. FlowersRobert M. HoffmanDavid J. Adams Original Article 03 June 2003 Pages: 253 - 261
